trial · primary record
Hyperpolarized 13-C-pyruvate
Pancreatic Cyst
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2027-01-31 |
| Primary endpoint | Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 |
| Registry ID | NCT05873699 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:39.068Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05873699
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.